Document is current

Any future updates will be listed below

Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma

Crossref DOI link: https://doi.org/10.1007/s11060-014-1460-z

Published Online: 2014-05-07

Published Print: 2014-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark